• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • News
  • Press Releases
Navigation
  • Press Releases
  • Media Coverage

Press Releases

  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Ceapro Reports Increased Sales in Third Quarter and Nine-Month Period of 2008

November 27, 2008

Ceapro Grants Stock Options to All Employees, Board Re-elected at AGM

September 2, 2008

Ceapro Reports Record Sales for Second Quarter 2008, Announces Strategic Review Initiatives at AGM

August 27, 2008

Ceapro Appeals on Litigation Management Focuses on Building Shareholder Value

July 22, 2008

Departure of Mr. Mark Redmond, Ph.D. as President & CEO of CEAPRO

July 4, 2008

Ceapro to Review Litigation Claims

June 9, 2008

Ceapro Announces Granting of Stock Options

January 7, 2008

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap